Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Arca Biopharma Inc (ABIO)
Arca Biopharma Inc (ABIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 23,589
  • Shares Outstanding, K 14,501
  • Annual Sales, $ 0 K
  • Annual Income, $ -5,340 K
  • 60-Month Beta 1.17
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.58
Trade ABIO with:

Options Overview Details

View History
  • Implied Volatility 371.90% ( +27.21%)
  • Historical Volatility 29.00%
  • IV Percentile 90%
  • IV Rank 58.92%
  • IV High 611.90% on 10/18/23
  • IV Low 27.73% on 07/17/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 1
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 234
  • Open Int (30-Day) 254

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5700 +3.82%
on 02/21/24
1.7500 -6.86%
on 01/26/24
+0.0200 (+1.24%)
since 01/22/24
3-Month
1.5600 +4.49%
on 01/19/24
1.9500 -16.41%
on 11/28/23
-0.2400 (-12.83%)
since 11/22/23
52-Week
1.5600 +4.49%
on 01/19/24
2.2700 -28.19%
on 03/02/23
-0.4900 (-23.11%)
since 02/22/23

Most Recent Stories

More News
ARCA biopharma Announces Second Quarter 2022 Financial Results

Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options ...

ABIO : 1.6300 (+0.20%)
Emerson Helping Albioma Become a Fully Renewable Energy Provider

Global technology and software company Emerson (NYSE: EMR) has been selected by Albioma (PAR: ABIO), a French independent energy provider, to help transition its coal-fired Bois Rouge plant to 100% renewable...

ABIO : 1.6300 (+0.20%)
EMR : 105.29 (+0.31%)
Jacob Ma-Weaver Joins ARCA biopharma Board of Directors

WESTMINSTER, Colo., June 21, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO) today announced that Jacob Ma-Weaver has joined its Board of...

ABIO : 1.6300 (+0.20%)
CPC Clinical Research Announces Dr. Connie Hess Receives Paul Dudley White Award For rNAPc2 in COVID 19 Presentation at the American Heart Association Vascular Discovery Scientific Sessions

- Dr. Hess was selected as the recipient of an American Heart Association 2022 Paul Dudley White International Scholar Award, which is presented to the primary author of the highest ranked abstract submitted...

ABIO : 1.6300 (+0.20%)
ARCA biopharma Retains Ladenburg Thalmann to Support Strategic Options Review

WESTMINSTER, Colo., May 05, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO) today announced that it has retained Ladenburg Thalmann &...

ABIO : 1.6300 (+0.20%)
ARCA biopharma Announces First Quarter 2022 Financial Results

Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options ...

ABIO : 1.6300 (+0.20%)
ARCA biopharma Establishes Special Committee of the Board of Directors

WESTMINSTER, Colo., April 18, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine...

ABIO : 1.6300 (+0.20%)
ARCA biopharma Reports Topline Results for ASPEN-COVID-19 Phase 2b Clinical Trial

For the entire cohort of COVID-19 hospitalized patients, the pooled lower and higher rNAPc2 dose groups demonstrated a reduction compared to baseline in...

ABIO : 1.6300 (+0.20%)
ARCA biopharma Announces 2021 Financial Results and Provides Corporate Update

Topline data from Phase 2b ASPEN-COVID-19 clinical trial evaluating rNAPc2 as a potential treatment for COVID-19 anticipated in the last week of March...

ABIO : 1.6300 (+0.20%)
Data on Gencaro Impact on Prevention of Bradycardia Published in Heart Rhythm O2

Clinically important bradycardia is common in heart failure (HF) patients with persistent or paroxysmal atrial fibrillation (AF)In a Phase 2B clinical...

ABIO : 1.6300 (+0.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ARCA biopharma, Inc., a biopharmaceutical company, develops genetically-targeted therapies for heart failure and cardiovascular diseases. It is positioned to bring personalized therapies for the treatment of cardiovascular disease, through the use of genetics. Complementing the Company's cardiovascular...

See More

Key Turning Points

3rd Resistance Point 1.6867
2nd Resistance Point 1.6633
1st Resistance Point 1.6467
Last Price 1.6300
1st Support Level 1.6067
2nd Support Level 1.5833
3rd Support Level 1.5667

See More

52-Week High 2.2700
Fibonacci 61.8% 1.9988
Fibonacci 50% 1.9150
Fibonacci 38.2% 1.8312
Last Price 1.6300
52-Week Low 1.5600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar